Laurie Toich, Assistant Editor

A new treatment for hepatitis B significantly reduced viral load in 4 weeks.

Infertility and breast density may impact the risk of cancer.

A new treatment for hepatitis B significantly reduced viral load in 4 weeks.

Infertility and breast density may impact the risk of cancer.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

Health insurance and financial assistance aids survival in less fortunate patients with leukemia.

Oral cancer drugs increased six-fold within the last 14 years.

Nuplazid (pimavanserin) treats hallucinations and delusions associated with Parkinson’s disease-related psychosis.

Top news of the day from across the healthcare landscape.

Broadly neutralizing antibodies were found to protect monkeys from an HIV-like virus.

JAK2 could potentially cause treatment resistance in TNBC.

JAK2 could potentially cause treatment resistance in TNBC.

New tool can detect chemical changes in DNA associated with liver fibrosis.

Vitamin D deficiency has been associated with different cancer types, such as breast, lung, colon, and bladder cancers.

Inhibitors of the protein galectin-8 may offer hope for treatment of several chronic inflammatory diseases.

Evaluating prior unsuccessful therapies could potentially improve psoriasis treatment.

Program found to control costs and decrease use of acute care.

A combination of blocking glucagon and insulin replacement therapy could normalize blood sugar levels.

Major pharmacy chains allow patients to access their prescription records while promoting personal control of health data.

Top news of the day from across the healthcare landscape.

Treatment costs climb with advanced-stage breast cancer compared with earlier stages.

Methotrexate and decadron could lower relapse rates of patients with acute lymphoblastic leukemia.

Rigosertib show promise in cancers with mutations in RAS genes.

An HIV PrEP program would cost about $44 billion, but could prevent 21,500 new infections.

An HIV PrEP program would cost about $44 billion, but could prevent 21,500 new infections.

Possible link found between an antiviral treatment for HBV and an increased risk of colorectal and cervical cancers.

Top news of the day from across the healthcare landscape.

Patients with moderate-to-severe plaque psoriasis covered by Medicare are less likely to adhere to their medication regimen.

Current HIV criminalization laws may be unfairly biased due to assumptions about intent to transmit the virus in sexual activity.